Abstract-Central pulse pressure (PP) can be noninvasively derived using the radial artery tonometric methods. 
C hronic kidney disease (CKD) confers a substantial risk of cardiovascular target organ damage, especially when kidney function falls below 60 mL/min per 1.73 m 2 , corresponding with National Kidney Foundation stages 3, 4, and 5, 1,2 that appears inadequately explained by traditional cardiovascular risk factors. 3 One goal of the Chronic Renal Insufficiency Cohort (CRIC) Study is to examine traditional and novel risk factors for cardiovascular target organ damage and for progressive loss of kidney function in a diverse population with CKD. 4 High blood pressure is known to influence the course of kidney disease progression. 5 In recent years some data suggest that the pulse pressure (PP; the difference of systolic and diastolic blood pressures) as derived from the standard brachial blood pressure measurement is better correlated than traditional blood pressure measures (systolic and diastolic) to the rate at which estimated glomerular filtration rates (eGFRs) decline in CKD. 6 Measurements of central PP (CPP) have been used for Ͼ2 decades in an attempt to further improve on the predictive value of standard brachial blood pressure measurements. 7 Studies have shown that there is substantial variability in the level of blood pressure in the aorta between people with similar brachial blood pressure measurements that is difficult to estimate without performing either an invasive or a noninvasive assessment of aortic pressure. 8 The increasing use of validated noninvasive devices that estimate central blood pressure profiles based on radial artery tonometry has facilitated the incorporation of these measurements into prospective cohort studies, such as the Anglo-Cardiff Collaborative Trial, 9 the Strong Heart Study, 10 and the CRIC Study (which included measurements of central [aortic] PP using radial artery tonometry as an ancillary study beginning in 2005).
Aging has a marked effect on the relationship between CPP and brachial PP, as does female sex. 11 However, little is known about the determinants of central aortic pressure pulse in the setting of CKD. Thus, we aimed to determine clinical factors independently associated with CPP in CKD and to evaluate how well brachial PP correlates with CPP in a large, ethnically diverse population of men and women with CKD.
Methods

Participants
Enrollment characteristics of the CRIC Study have been described previously in detail. 12 Central aortic PP measurements were adopted into the CRIC protocol beginning at the second annual follow-up visit, and all of the participants enrolled in the CRIC Study were invited to become part of this ancillary protocol. The procedures were approved by the institutional review boards at the 7 clinical centers, and all of the participants provided written informed consent.
Procedures
CPP measurements were performed supine after Ն5 minutes of rest using the SphygmoCor PVx System (AtCor Medical) via the right radial artery at all of the CRIC sites. All of the personnel were trained and certified to take blood pressure measurements in the dominant arm with a Tyco aneroid sphygmomanometer using American Heart Association standards and to perform the central pressure measurements using radial artery tonometry. 13, 14 The operator captured 10 seconds of stable radial artery waveform. PP was defined as the difference between the systolic and the diastolic blood pressures in millimeters of mercury. When these data were derived from standard blood pressure measurement it was brachial PP; when derived by algorithm from the radial artery waveform it was CPP.
Laboratory Measures
Hemoglobin values were measured directly at the laboratories of each of the centers. Standard laboratory testing (eg, serum creatinine, glucose, uric acid, calcium, and phosphorous) was performed at the CRIC central laboratory in the University of Pennsylvania. The eGFR was determined according to the abbreviated Modification of Diet in Renal Disease formula using creatinine values calibrated to the Cleveland Clinic Laboratory. 15 Some laboratory results were only available at the baseline visit and are noted in Table 1 .
Race
Race was classified as American Indian/Alaskan Native, Asian/ Asian American, black, Native Hawaiian/Other Pacific Islander, or white based on participant self-report.
CPP Data
The data reported here represent central aortic PP measures obtained on participants whose second annual follow-up visit occurred on or before March 31, 2009 . The augmentation index is a ratio that reflects the portion of the CPP derived from pulse wave reflection.
Statistical Analyses
Continuous data are presented as meanϮSD. Categorical variables are expressed as proportions. Independent variables were prespecified for analyses based on previous studies showing a relation to CPP (eg, age or systolic blood pressure) or because they may affect PP and are known to be affected by kidney disease (eg, calcium or hemoglobin). A plot of CPP in our population showed a substantial rightward skew, and analyses were performed on both raw CPP data and natural log-transformed data. Univariable regression models for CPP were used to assess the relationship between CPP and the selected variable. We performed multivariable linear regression to examine the associations between variables of interest and CPP. 16 All of the parameters significant at a PՅ0.20 level in univariable regression were entered into both forward and backward selection algorithms. Where variables were known to be strongly correlated with each other (eg, serum creatinine and eGFR) only the one with the stronger association was entered. Variables significant at the PՅ0.05 level in the multivariable model were retained in the final model.
We considered 2 multivariable regression models: one with natural log-transformed (Ln)CPP as the outcome, without measures of brachial blood pressure as predictor and one with LnCPP as the outcome, including measures of natural log-transformed brachial PP and brachial mean arterial pressure as predictors. All of the multivariable models were adjusted for clinical site. Analyses were executed as in SAS 9.1 (SAS Institute).
Results
Demographic characteristics of all of the participants eligible for CPP measurement at the year 2 follow-up visit of the CRIC cohort are shown in Table 1 , overall and stratified by those who did or did not have a successful CPP measurement. We anticipated data loss on Ϸ20% of participants (because of arrhythmia and other difficulties with waveform capture), and we were unable to obtain or use measurements on 746 (22.7%) of 3277 eligible participants. Figure 1 shows the frequency distribution of CPP determinations in the overall sample and stratified by diabetes mellitus status. The tertiles of the CPP were Ͻ36 mm Hg, 36 to 51 mm Hg, and Ͼ51 mm Hg with an overall mean value of 46Ϯ19 (ϮSD). (Table 2) . A CPP of 50 mm Hg was shown recently to be a significant independent predictor of cardiovascular outcomes in the Strong Heart Study, where it represented the lower boundary of the highest quartile. 17 Figure 2 shows the increasing proportion (percentage) of those within each declining eGFR strata in CRIC that had a CPP Ն50 mm Hg. Table 2 displays the results of univariable regression of demographic, hemodynamic, and laboratory data of our participants on CPP. The strongest univariable associations with CPP were presence of diabetes mellitus, brachial PP and brachial systolic blood pressure, decade of age, female sex, nonwhite ethnicity, serum calcium, the number of antihypertensive medications taken regularly, and lower eGFR level.
Multivariable analyses are described in Tables 3 through 5 . In the absence of an adjustment for brachial blood pressure (Table 3) , there were independent contributions to the LnCPP that included age (10 years), sex, diabetes mellitus, heart rate, glycosylated hemoglobin, hemoglobin, glucose, and serum parathyroid hormone concentration at baseline. When brachial PP and brachial mean arterial pressure were incorporated into the model (Table 4) , sex was the strongest nonblood pressure predictor term for LnCPP followed by age (10 years), diabetes mellitus, weight (per 10 kg), and heart rate. Weight and heart rate had negative influences on LnCPP.
Glucose, glycosylated hemoglobin, hemoglobin, and parathyroid hormone concentrations were no longer independently associated with LnCPP. Table 5 shows that most of the variability in the multivariable model predicting LnCPP is explained from the natural log-transformed brachial PP. In the supplemental Table (please see the online Data Supplement at http://hyper.ahajournals.org), we expanded our multivariable regression incorporating the time to central wave reflection and augmentation index into the model to pursue these avenues as possible mechanisms by which these clinical factors might influence CPP, demonstrating that addition of augmentation index may mediate the effect of several clinical predictors of CPP, whereas aortic time to central wave reflection was not a predictor of CPP in univariate or multivariable analysis. We refer the reader to the online Data Supplement available at http://hyper.ahajournals.org for further details. When discrete intervals of brachial PPs were plotted against their corresponding levels of CPP, there was a substantial overlap within the associated CPP values (Figure 3 ).
Discussion
We performed central aortic pressure measurements on a population of 2531 participants recruited specifically with impaired kidney function but not on dialysis, of whom approximately half were diabetic. Our results indicate that that CPP values are positively and independently correlated with increasing brachial PP, older age, female sex, and the presence of diabetes mellitus in a population of participants with CKD. In addition we found a significant, although weaker, negative correlation between weight and heart rate, as noted in some other studies of central blood pressure. 18 Our results confirm a substantial overlap in CPPs when participants are stratified by discrete levels of brachial-derived PPs (Figure 3 ). This report adds to the literature, because it examined a uniquely large cohort with a spectrum of kidney dysfunction at high cardiovascular risk, a population infrequently studied using central pressure measures. Reproducibility of central blood pressure measurements has been shown by others in non-CKD populations. 19, 20 In addition, our previous work in this CKD population, as well as that of others, 21, 22 shows good reproducibility supporting the validity of these findings. Central pressure measurements offer the opportunity to estimate the PP that the left ventricle and aorta actually "see." 7 As the pressure wave travels from the elastic central vessels into the muscular arterial conduits, there is a varying degree of increase ("amplification") in the systolic pressure, whereas there is little change in diastolic or mean arterial pressure in the circulation. This rise in blood pressure is often expressed as an amplification ratio (defined as the PP in the brachial artery divided by the central aortic PP). 8 As shown in our study and by others, knowledge of the brachial blood pressure is an imperfect estimate of central blood pressure levels 8 (Figure 3) .
Studies comparing brachial PP compared with CPP using outcomes such as left ventricular mass or the occurrence of cardiovascular target organ damage (carotid intima-media thickness or death) have shown independent predictive value for CPP measurements. 10, [23] [24] [25] [26] On the other hand, a recent meta-analysis of cardiovascular outcomes in longitudinal studies in which central hemodynamic measures were incorporated showed that, whereas both CPP and the augmentation index predicted cardiovascular events and mortality, only the augmentation index did so independent of the brachial blood pressure. 27 The kidney is particularly vulnerable to increased pulsatile stress, as reviewed recently by Loutzenhiser et al. 28 Patients with CKD 1,29 and end-stage renal disease have substantial cardiovascular risk. 30, 31 In a study of 349 subjects with CKD stages 4/5, a brachial PP of Ͼ80 mm Hg was an independent predictor of cardiovascular death or progression to end-stage renal disease requiring dialysis. 32 In a non-CKD population, the Strong Heart Study, CPP measures were superior to brachial PP in predicting carotid intima-media thickness and cardiovascular outcomes. 10 A second analysis of the Strong Heart Study data, including additional follow-up time, derived a CPP of Ն50 mm Hg as a clinical meaningful threshold for increased cardiovascular target organ damage. 17 For that reason we chose to show the proportion of our populations, stratified by kidney function, with a CPP Ͼ50 mm Hg, recognizing that our study is observational, whereas the Strong Heart Study data were longitudinal (Figure 2 ). The recognition that reduced kidney function in CKD is related strongly to cardiovascular disease morbidity and mortality has stimulated an ongoing search for biological markers beyond traditional Framingham risk factors because these explain some but not all of the extra cardiovascular burden in CKD. 1, 33 Our study had several limitations. We were unable to successfully capture radial pulse waveforms in Ϸ23% of our CKD participants, and there were differences in patient characteristics between those with versus without successful waveforms. Importantly, the brachial PP was identical in both groups. Some laboratory values are only available at the baseline visit, which occurred Ϸ2 years before the first CPP measurement, and these may have changed between baseline and the second year follow-up visit. This caveat applies especially to glycosylated hemoglobin and serum parathyroid hormone concentrations. Lastly, our participants take a number of antihypertensive medications that may affect CPP, although we did not find an independent effect of the number of antihypertensive agent classes taken.
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Perspectives
Our findings in this large, diverse, and unique CKD population show associations of age, sex, diabetes mellitus, heart rate, and brachial systolic and PPs with CPP. These are important associations in a group with such exceptional cardiovascular disease burden and are imperfectly represented by standard brachial PP determinations. The low resistance nature of the renal circulation predisposes the kidney to pressure-mediated damage. 34 Brachial PP measures have been shown to predict both the development of CKD and the rate of loss of kidney function when CKD is already present. Knowledge of brachial PP is an imperfect predictor of CPPs, thus, measures of CPP may be useful in patients with CKD to quantify their risk of cardiovascular disease and CKD progression. The role of CPP in predicting progressive kidney function loss, as well as incident cardiovascular disease, in established mild-to-moderate CKD remains to be seen. Longitudinal data from CRIC and other studies pursuing the value of central blood pressure measures will clarify further this important issue. 
